DigitalDx Ventures — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
GLX Analytixglxanalytix.cominJul 2022
GLX Analytix develops a blood test platform that measures glycocalyx fragments and uses AI/ML to create disease-specific biomarker signatures for diagnosing and monitoring brain diseases including neuropsychiatric, neurodegenerative, and autoimmune conditions.
AI & Machine LearningDigital HealthMedical Devices
Brian(Founder & CEO)
Co-investorsVaekstfonden
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.